Neuropeptide Y Leu7Pro Polymorphism Associated With the Metabolic Syndrome and Its Features in Patients With Coronary Artery Disease-Reference-Cited by-同舟云学术

Neuropeptide Y Leu7Pro Polymorphism Associated With the Metabolic Syndrome and Its Features in Patients With Coronary Artery Disease

Published:2012-02-03 Issue:1 Volume:64 Page:40-45
ISSN:0003-3197
Container-title:Angiology
language:en
Short-container-title:Angiology

Author:

Masoudi-Kazemabad Ali¹,Jamialahmadi Khadijeh²,Moohebati Mohsen³,Mojarrad Majid⁴,Manshadi Raheleh Dehghan²,Akhlaghi Saeed⁵,Ferns Gordon A.⁶,Ghayour-Mobarhan Majid⁷

Affiliation:

1. Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran

2. Department of Modern Sciences and Technologies, School of Medicine, Faculty of Medicine, Mashhad University of Medical Sciences (MUMS), Mashhad, Iran

3. Cardiovascular Research Center, Faculty of Medicine, MUMS, Mashhad, Iran

4. Department of Genetics, Faculty of Medicine, MUMS, Mashhad, Iran

5. Deputy of Research, Faculty of Medicine, MUMS, Mashhad, Iran

6. Institute for Science and Technology in Medicine, University of Keele, Guy Hilton Research Centre, Thornburrow Drive, Stoke-on-Trent, Staffordshire, UK

7. Cardiovascular Research Center, Biochemistry and Nutrition Research Center, Faculty of Medicine, MUMS, Mashhad, Iran

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/0003319711435149

Reference26 articles.

1. The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men

2. Prevalence of coronary artery disease risk factors in Iran: a population based survey

3. Anthropometric Indices of Obesity and the Prediction of Cardiovascular Risk Factors in an Iranian Population

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuropeptide Y: An Update on the Mechanism Underlying Chronic Intermittent Hypoxia-Induced Endothelial Dysfunction;Frontiers in Physiology;2021-08-27

2. An overview of glucagon-like peptide-1 receptor agonists for the treatment of metabolic syndrome: A drug repositioning;IRAN J BASIC MED SCI;2020

3. Pharmacology of dipeptidyl peptidase-4 inhibitors and its use in the management of metabolic syndrome: a comprehensive review on drug repositioning;DARU Journal of Pharmaceutical Sciences;2019-01-23

4. A Review of Single-Nucleotide Polymorphisms in Orexigenic Neuropeptides Targeting G Protein-Coupled Receptors;ACS Chemical Neuroscience;2018-05-01

5. Peripherally Administered Y2-Receptor Antagonist BIIE0246 Prevents Diet-Induced Obesity in Mice With Excess Neuropeptide Y, but Enhances Obesity in Control Mice;Frontiers in Pharmacology;2018-04-05